Phase 2 Study of Nuzefatide Pevedotin, an EphA2-targeting Bicycle Drug Conjugate (BDC), in Patients (Pts) With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

nuzefatide pevedotin (BT5528) - Bicycle Therap

Do-Youn Oh; Babar Bashir; Kenneth Yu; Hani Babiker; Tanios Bekaii-Saab; Khalid Jazieh; Joon Oh Park; Daniel Peterson; Vienna Reichert; Kian-huat Lim

Jul 17, 2026